Skip Navigation


JAC Advance Access originally published online on June 4, 2009
Journal of Antimicrobial Chemotherapy 2009 64(2):375-378; doi:10.1093/jac/dkp199
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
64/2/375    most recent
dkp199v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Leonardi, D.
Right arrow Articles by Salomon, C. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leonardi, D.
Right arrow Articles by Salomon, C. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Original research

High efficacy of albendazole–PEG 6000 in the treatment of Toxocara canis larva migrans infection

Darío Leonardi1,2, Claudia Echenique3, María C. Lamas1,2 and Claudio J. Salomon1,2,*

1 Area Tecnología Farmacéutica, Departamento Farmacia, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Suipacha 531, 2000 Rosario, Argentina 2 Instituto de Química de Rosario, IQUIR-CONICET, Suipacha 531, 2000 Rosario, Argentina 3 Area Parasitología, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Suipacha 531, 2000 Rosario, Argentina

Received 23 February 2009; returned 23 March 2009; revised 15 April 2009; accepted 8 May 2009


* Corresponding author. Tel: +54-341-4804594; Fax: +54-341-4370477; E-mail: csalomon{at}fbioyf.unr.edu.ar/claudiosalomon{at}hotmail.com

Objectives: In vitro and in vivo experiments were used to determine whether albendazole–PEG 6000 solid dispersions would be effective in the treatment of Toxocara canis larva migrans.

Methods: Albendazole–PEG 6000 (1:1, 1:5 and 1:9 ratios) solid dispersions were prepared by the solvent evaporation method. The morphology of the particles was evaluated by scanning electron microsocopy (SEM), and in vitro dissolution assays were also carried out. Mice were infected with T. canis and then treated orally with albendazole–PEG 6000 systems or albendazole suspended in water. The anthelmintic effect was examined at 28 days post-infection (p.i.). The number of larvae recovered from mice treated with albendazole alone and those treated with albendazole–PEG 6000 were compared with the numbers from the placebo group.

Results: Dissolution of albendazole from solid dispersions was markedly enhanced by increasing the polymer concentration. At a 1:9 drug:polymer ratio, >90% of the albendazole was dissolved in 10 min. SEM showed microparticles to be of small spherical shape compared with the pure components. In vivo evaluation of larva migration showed that both albendazole–PEG 6000 solutions exhibited a greater anthelmintic effect in the brain (0 larvae/mouse). In addition it was also found that liver and lung showed a significant decrease in the number of larvae. Evaluation of vehicle toxicity (PEG 6000 in water) showed a mice survival rate of 100% at the assayed concentrations.

Conclusions: These data suggest that albendazole–PEG 6000 solid dispersions markedly increased the effectiveness of albendazole against the migratory activity of larvae. Particularly, these polymeric solutions were able to totally prevent migration of larvae to the mouse brain.

Keywords: solid dispersions , drug dissolution , human toxocariasis , nematocide activity


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.